GHST World Inc.: peers
GHST World Inc. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.
GHST World Inc., ENvue Medical, Inc., Escalon Medical Corp., Nu-Med Plus Inc., Qlife Holding AB (publ), Hemcheck Sweden AB (publ), Rafina Innovations Inc.: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.
Side by side#
Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.
| Measure | GHST World Inc.base GHST Percentile in Healthcare Percentile in its country | ENvue Medical, Inc. FEED · 🇺🇸 US Percentile in Healthcare Percentile in USA | Escalon Medical Corp. ESMC · 🇺🇸 US Percentile in Healthcare Percentile in USA | Nu-Med Plus Inc. NUMD · 🇺🇸 US Percentile in Healthcare Percentile in USA | Nexalin Technology, Inc. NXL · 🇺🇸 US Percentile in Healthcare Percentile in USA | Qlife Holding AB (publ) QLIFE.ST · 🇸🇪 SE Percentile in Healthcare Percentile in Sweden | Hemcheck Sweden AB (publ) HEMC.ST · 🇸🇪 SE Percentile in Healthcare Percentile in Sweden | Rafina Innovations Inc. VICA · 🇬🇧 GB Percentile in Healthcare Percentile in UK | Group median |
|---|---|---|---|---|---|---|---|---|---|
| Size | |||||||||
| Market cap (Better neither way: ranked highest first) | $1 Mlast known, Jan 7, 2022 · Market dataLast known value: no current one5th of 8 | $2 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one2nd of 8 | $2 Mlast known, Jul 30, 2023 · Market dataLast known value: no current one2nd of 8 | $2 Mlast known, Jan 7, 2022 · Market dataLast known value: no current one2nd of 8 | $2 MOct 27, 2026 · Market data1st of 8 | $1 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one5th of 8 | $1 Mlast known, Jul 30, 2023 · Market dataLast known value: no current one5th of 8 | $1 Mlast known, Jan 7, 2022 · Market dataLast known value: no current one5th of 8 | $2 M8 ranked |
| Revenue (Better neither way: ranked highest first) | $0 MFY2026 · SEC4th of 4 | $3 MFY2025 · SEC2nd of 4 | $13 MFY2026 · SEC1st of 4 | —— | $0 MFY2025 · SEC3rd of 4 | —— | —— | —— | $1 M4 ranked |
| Net income (Higher is better) | $-0 MFY2026 · SEC3rd of 5 | $-18 MFY2025 · SEC5th of 5 | $4 MFY2026 · SEC1st of 5 | $-0 MFY2025 · SEC2nd of 5 | $-8 MFY2025 · SEC4th of 5 | —— | —— | —— | $-0 M5 ranked |
| Employees (Better neither way: ranked highest first) | —— | —— | 40June 30, 2026 · Profile1st of 2 | —— | 8December 31, 2025 · Profile2nd of 2 | —— | —— | —— | 242 ranked |
| Growth | |||||||||
| Revenue growth (Higher is better) | ———— | -0.4%FY2025 · SEC2nd of 225th28th | +5.7%FY2026 · SEC1st of 239th48th | ———— | ———— | ———— | ———— | ———— | +2.7%2 ranked |
| Revenue growth, 3 years a year (Higher is better) | ———— | +50.4%FY2025 · SEC1st of 288th96th | +1.5%FY2026 · SEC2nd of 231st38th | ———— | ———— | ———— | ———— | ———— | +25.9%2 ranked |
| Margins and returns | |||||||||
| Gross margin (Higher is better) | ———— | 5.9%FY2025 · SEC2nd of 24th5th | 43.7%FY2026 · SEC1st of 228th56th | ———— | ———— | ———— | ———— | ———— | 24.8%2 ranked |
| Operating margin (Higher is better) | ———— | -897.6%FY2025 · SEC2nd of 21st0th | 0.4%FY2026 · SEC1st of 258th41st | ———— | ———— | ———— | ———— | ———— | -448.6%2 ranked |
| Net margin (Higher is better) | ———— | -712.9%FY2025 · SEC2nd of 23rd1st | 31.5%FY2026 · SEC1st of 295th95th | ———— | ———— | ———— | ———— | ———— | -340.7%2 ranked |
| Free cash flow margin (Higher is better) | ———— | -369.8%FY2025 · SEC2nd of 29th2nd | -3.1%FY2026 · SEC1st of 247th28th | ———— | ———— | ———— | ———— | ———— | -186.5%2 ranked |
| Return on equity (Higher is better) | ———— | -106.5%FY2025 · SEC2nd of 323rd10th | 102.2%FY2026 · SEC1st of 399th99th | ———— | -221.3%FY2025 · SEC3rd of 39th4th | ———— | ———— | ———— | -106.5%3 ranked |
| Valuation | |||||||||
| Price to sales (Better neither way: ranked highest first) | ———— | ———— | ———— | ———— | 7.8×price Oct 27, 2026 · Market dataonly one with it68th86th | ———— | ———— | ———— | 7.8×— |
| Price to book (Better neither way: ranked highest first) | ———— | ———— | ———— | ———— | 0.6×price Oct 27, 2026 · Market dataonly one with it8th8th | ———— | ———— | ———— | 0.6×— |
| Financial strength | |||||||||
| Interest cover (Higher is better) | ———— | ———— | 5.0×FY2026 · SEC1st of 286th74th | -5.0×FY2025 · SEC2nd of 255th30th | ———— | ———— | ———— | ———— | 0.0×2 ranked |
| Scorecard | |||||||||
| Scorecard (Higher is better) | —— | 3 of 13FY2025 · Scorecard3rd of 4 | 8 of 15FY2026 · Scorecard1st of 4 | 3 of 9FY2025 · Scorecard2nd of 4 | 2 of 12FY2025 · Scorecard4th of 4 | —— | —— | —— | 28% passed4 ranked |
| Valuation checks (Higher is better) | —— | —— | —— | —— | 1 of 4FY2025 · Scorecardonly one with it | —— | —— | —— | 25% passed— |
| Growth checks (Higher is better) | —— | 2 of 6FY2025 · Scorecard3rd of 4 | 4 of 6FY2026 · Scorecard1st of 4 | 1 of 2FY2025 · Scorecard2nd of 4 | 0 of 1FY2025 · Scorecard4th of 4 | —— | —— | —— | 42% passed4 ranked |
| Profitability checks (Higher is better) | —— | 0 of 5FY2025 · Scorecard2nd of 4 | 3 of 5FY2026 · Scorecard1st of 4 | 0 of 2FY2025 · Scorecard2nd of 4 | 0 of 3FY2025 · Scorecard2nd of 4 | —— | —— | —— | 0% passed4 ranked |
| Financial health checks (Higher is better) | —— | 1 of 2FY2025 · Scorecard1st of 4 | 1 of 3FY2026 · Scorecard2nd of 4 | 1 of 4FY2025 · Scorecard4th of 4 | 1 of 3FY2025 · Scorecard2nd of 4 | —— | —— | —— | 33% passed4 ranked |
| Shareholder returns checks (Higher is better) | —— | —— | 0 of 1FY2026 · Scorecard2nd of 3 | 1 of 1FY2025 · Scorecard1st of 3 | 0 of 1FY2025 · Scorecard2nd of 3 | —— | —— | —— | 0% passed3 ranked |
| Ownership | |||||||||
| Held by institutions (Better neither way: ranked highest first) | —— | —— | —— | —— | 0.8%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are inonly one with it | —— | —— | —— | 0.8%— |
| Institutions holding (Better neither way: ranked highest first) | —— | —— | —— | —— | 92026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are inonly one with it | —— | —— | —— | 9— |
Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).
Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = GHST World Inc.: How market caps are worked out; ENvue Medical, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Escalon Medical Corp.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Nu-Med Plus Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Nexalin Technology, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Qlife Holding AB (publ): How market caps are worked out; Hemcheck Sweden AB (publ): How market caps are worked out; Rafina Innovations Inc.: How market caps are worked out.
Where each stands in its sector and country: Operating margin#
The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.
| Company | Operating margin | In its sector | In its country |
|---|---|---|---|
| GHST World Inc. | — | — | — |
| ENvue Medical, Inc. | -897.6%FY2025 | 1st percentile in Healthcaremedian -7.7%, 674 companies | 0th percentile in USAmedian 3.5%, 2,595 companies |
| Escalon Medical Corp. | 0.4%FY2026 | 58th percentile in Healthcaremedian -7.7%, 674 companies | 41st percentile in USAmedian 3.5%, 2,595 companies |
| Nu-Med Plus Inc. | — | — | — |
| Nexalin Technology, Inc. | — | — | — |
| Qlife Holding AB (publ) | — | — | — |
| Hemcheck Sweden AB (publ) | — | — | — |
| Rafina Innovations Inc. | — | — | — |
Revenue by fiscal year, and the rank in the group#
Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).
Revenue
Rank in the group
| Fiscal year | GHST World Inc. | ENvue Medical, Inc. | Escalon Medical Corp. | Nu-Med Plus Inc. | Nexalin Technology, Inc. | Qlife Holding AB (publ) | Hemcheck Sweden AB (publ) | Rafina Innovations Inc. |
|---|---|---|---|---|---|---|---|---|
| 2026 | $0 MSEC2nd | — | $13 MSEC1st | — | — | — | — | — |
| 2025 | $0 MSEC4th | $3 MSEC2nd | $12 MSEC1st | — | $0 MSEC3rd | — | — | — |
| 2024 | $0 MSEC4th | $3 MSEC2nd | $12 MSEC1st | — | $0 MSEC3rd | — | — | — |
| 2023 | — | $2 MSEC2nd | $12 MSEC1st | — | $0 MSEC3rd | — | — | — |
| 2022 | — | $1 MSEC2nd | $11 MSEC1st | — | — | — | — | — |
| 2021 | — | $2 MSEC2nd | $10 MSEC1st | — | $0 MSEC3rd | — | — | — |
| 2020 | — | $1 MSEC2nd | $9 MSEC1st | — | — | — | — | — |
| 2019 | — | $1 MSEC2nd | $10 MSEC1st | — | — | — | — | — |
| 2018 | — | $0 MSEC2nd | $11 MSEC1st | — | — | — | — | — |
| 2017 | — | $0 MSEC2nd | $11 MSEC1st | — | — | — | — | — |
| 2016 | — | $0 MSEC2nd | $12 MSEC1st | — | — | — | — | — |
| 2015 | — | $0 MSEC2nd | $13 MSEC1st | — | — | — | — | — |
Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.
Suggested peers of GHST World Inc.#
Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.
- ENvue Medical, Inc.FEED · 🇺🇸 USASame industry: Medical Devices · Similar size: $2 M market cap against $1 M · Ratios of the last two fiscal years on fileMarket cap $2 M (last known, Jan 5, 2024) · revenue $3 M (year to December 2025)80 of 100 (industry or sector 50 + size 26 + figures on file 5)In the group
- Escalon Medical Corp.ESMC · 🇺🇸 USASame industry: Medical Devices · Similar size: $2 M market cap against $1 M · Ratios of the last two fiscal years on fileMarket cap $2 M (last known, Jul 30, 2023) · revenue $13 M (year to June 2026)80 of 100 (industry or sector 50 + size 26 + figures on file 5)In the group
- Nu-Med Plus Inc.NUMD · 🇺🇸 USASame industry: Medical Devices · Similar size: $2 M market cap against $1 M · Ratios of the last two fiscal years on fileMarket cap $2 M (last known, Jan 7, 2022)80 of 100 (industry or sector 50 + size 26 + figures on file 5)In the group
- Nexalin Technology, Inc.NXL · 🇺🇸 USASame industry: Medical Devices · Similar size: $2 M market cap against $1 M · Ratios of the last two fiscal years on fileMarket cap $2 M (Oct 27, 2026) · revenue $0 M (year to December 2025)80 of 100 (industry or sector 50 + size 25 + figures on file 5)In the group
- Qlife Holding AB (publ)QLIFE.ST · 🇸🇪 SwedenSame industry: Medical Devices · Similar size: $1 M market cap against $1 MMarket cap $1 M (last known, Jan 5, 2024)80 of 100 (industry or sector 50 + size 30)In the group
- Hemcheck Sweden AB (publ)HEMC.ST · 🇸🇪 SwedenSame industry: Medical Devices · Similar size: $1 M market cap against $1 MMarket cap $1 M (last known, Jul 30, 2023)80 of 100 (industry or sector 50 + size 30)In the group
- Rafina Innovations Inc.VICA · 🇬🇧 UKSame industry: Medical Devices · Similar size: $1 M market cap against $1 MMarket cap $1 M (last known, Jan 7, 2022)80 of 100 (industry or sector 50 + size 30)In the group
- Nuwellis, Inc.NUWE · 🇺🇸 USASame industry: Medical Devices · Similar size: $3 M market cap against $1 M · Ratios of the last two fiscal years on fileMarket cap $3 M (Oct 30, 2026) · revenue $8 M (year to December 2025)78 of 100 (industry or sector 50 + size 23 + figures on file 5)+ Add
- Therma Bright Inc.JNX.F · 🇨🇦 CanadaSame industry: Medical Devices · Similar size: $1 M market cap against $1 MMarket cap $1 M (Oct 31, 2026)78 of 100 (industry or sector 50 + size 28)+ Add
- ENvizion Medical Ltd.ENVM.TA · 🇮🇱 IsraelSame industry: Medical Devices · Similar size: $2 M market cap against $1 MMarket cap $2 M (last known, Jan 5, 2024)76 of 100 (industry or sector 50 + size 26)+ Add
- Bionovate Technologies Corp.BIIOSame industry: Medical Devices · Similar size: $2 M market cap against $1 MMarket cap $2 M (last known, Jan 7, 2022)76 of 100 (industry or sector 50 + size 26)+ Add
- Emotra AB (publ)93Y.F · 🇸🇪 SwedenSame industry: Medical Devices · Similar size: $2 M market cap against $1 MMarket cap $2 M (last known, Jan 7, 2022)76 of 100 (industry or sector 50 + size 26)+ Add
Any figure over the years, other peers or a saved group: open this group in the peer workspace.